![Thierry Abribat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thierry Abribat
Algemeen Directeur bij Millendo Therapeutics SAS
Oorsprong van het eerstegraads netwerk van Thierry Abribat
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Amolyt Pharma SAS
![]() Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Millendo Therapeutics SAS
![]() Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.
7
| Subsidiary | Medical Specialties | 7 |
EUSA Pharma SAS
![]() EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France.
1
| Subsidiary | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thierry Abribat via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member | |
THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
MAINSTAY MEDICAL INTERNATIONAL | Medical Specialties | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Sofinnova Partners SAS
![]() Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
Sofimac Innovation SAS
![]() Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Director/Board Member Private Equity Investor | |
ODDO BHF SE
![]() ODDO BHF SE Major BanksFinance ODDO BHF SE provides banking and financial services. It specializes in private banking, asset management, as well as corporate and investment banking. The company was founded in 1854 and is headquartered in Frankfurt, Germany. | Major Banks | Chief Executive Officer | |
Aston SA
![]() Aston SA Information Technology ServicesTechnology Services Part of DBAY Advisors Ltd., Aston SA is a French digital services company that offers training and education solutions. The company is based in Vélizy, France. The company provides personalized advice and solutions to help individuals achieve their goals, regardless of their age or situation. Aston was acquired by SQLI SA, part of DBAY Advisors Ltd. on January 28, 2022. | Information Technology Services | Director/Board Member | |
INSEAD | College/University | Doctorate Degree Undergraduate Degree | |
University of Montréal | College/University | Undergraduate Degree Doctorate Degree | |
University of Paris Jussieu | College/University | Doctorate Degree | |
France Biotech Association
![]() France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
Bryan, Garnier & Co Ltd. (France) | Investment Banks/Brokers | Director of Research - Equity | |
Erasmus MC
![]() Erasmus MC Hospital/Nursing ManagementHealth Services Erasmus MC operates as an academic hospital. It is affiliated with the Erasmus University of Rotterdam, and home to its faculty of medicine. It has special units such as Neurosurgery, Cardiograph surgery, Neonatal and pediatric surgery and intensive care, Pediatric oncology and Level I trauma center. The company was founded in 2002 and is headquartered in Rotterdam, Netherlands. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
The University of Algiers | College/University | Doctorate Degree | |
Axess Vision Technology SA
![]() Axess Vision Technology SA Medical SpecialtiesHealth Technology Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France. | Medical Specialties | Director/Board Member | |
CERADROP SA
![]() CERADROP SA Industrial MachineryProducer Manufacturing CERADROP SA specializes in equipment for printed electronics. It designs and markets materials deposition digital printers exclusively for printed electronics industry and smart 3D printing. The firm provides ink formulation, equipment maintenance and support, and process development services. The company was founded in 2006 and is headquartered in Limoges, France. | Industrial Machinery | Director/Board Member | |
BEG Ingénierie SA
![]() BEG Ingénierie SA Engineering & ConstructionIndustrial Services BEG Ingénierie SA provides engineering, project management, architectural design, and construction services. It specializes in offices, turnkey logistics platforms, factories, hospitals, and shopping centers. The firm also offers consulting and implementation of sustainable development solutions to its portfolios. The company was founded by Robert Preslier, Hugues Golzio, Michel Maunoury, and Jean-Eric Cartry in 1966 and is headquartered in Orleans, France. | Engineering & Construction | Director/Board Member | |
Pfizer NV/SA | Corporate Officer/Principal Corporate Officer/Principal | ||
Ipsen NV
![]() Ipsen NV Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen NV is a Belgian biopharmaceutical company that improves patients' lives through research and innovation in oncology, rare disease, and neuroscience. Founded in 1982, the company is based in Merelbeke, Belgium. Ipsen is a global mid-sized biopharmaceutical company that focuses on improving patients' lives through its research and innovation in the field of oncology, rare diseases, and neuroscience. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SENSORION | Pharmaceuticals: Major | Director/Board Member | |
BIOM'UP | Medical Specialties | Director/Board Member | |
Natixis SA (Broker)
![]() Natixis SA (Broker) Investment Banks/BrokersFinance Natixis SA (Broker) is the securities brokerage division of Natixis SA (EPA: KN), a corporate and investment bank headquartered in Paris, France. They are ultimately owned by BCPE SA. The firm provides full spectrum of broking services to various investors. | Investment Banks/Brokers | Analyst-Equity | |
Sorbonne Université | College/University | Graduate Degree | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
ELSALYS BIOTECH | Pharmaceuticals: Major | Director/Board Member Founder | |
NEURONAX SA
![]() NEURONAX SA Pharmaceuticals: MajorHealth Technology NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France. | Pharmaceuticals: Major | Director/Board Member | |
Microphyt SA
![]() Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Biotechnology | Director/Board Member | |
Cosmo Tech SAS
![]() Cosmo Tech SAS Information Technology ServicesTechnology Services Cosmo Tech SAS provides software system and digital solutions. The firm develops a proprietary language called CoSML dedicated to the modeling and simulation of complex systems. The company was founded by Hugues de Bantel and Michel Morvan and is headquartered in Lyon, France. | Information Technology Services | Director/Board Member | |
Adienne SA
![]() Adienne SA Pharmaceuticals: OtherHealth Technology Adienne SA is a biopharmaceutical company engages in the provision of medical development. It focuses on orphan drugs for the treatment of various haematological and immunological diseases. The company was founded on Lugano, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
ORPHELIA Pharma SAS
![]() ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
IXALTIS SAS
![]() IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
VALBIOTIS | Biotechnology | Director/Board Member | |
Jazz Pharmaceuticals II SASU
![]() Jazz Pharmaceuticals II SASU Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals II SASU engages in the development of biopharmaceutical drugs, proteins and peptides, for the treatment of metabolic diseases and rare diseases. Its lead assets are pegcrisantaspase (Asparec), a PEGylated recombinant L-asparaginase from Erwinia chrysanthemi, and related intellectual property. The company was founded in 2008 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Opi Pharma | Chief Executive Officer | ||
Axcell Biotechnologies
![]() Axcell Biotechnologies Pharmaceuticals: MajorHealth Technology Axcell Biotechnologies manufactures pharmaceutical preparations. The private company is based in Lyon, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Syndicat De L’Industrie Du Médicament Vétérinaire
![]() Syndicat De L’Industrie Du Médicament Vétérinaire Miscellaneous Commercial ServicesCommercial Services Syndicat De L ’ Industrie Du Médicament Vétérinaire is a private company based in Paris, France. The French company operates as an association of medicinal, diagnostic, and devices manufacturer for animal health. | Miscellaneous Commercial Services | Director/Board Member | |
Urovant Sciences, Inc.
![]() Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Mainstay Medical Holdings Plc
![]() Mainstay Medical Holdings Plc Financial ConglomeratesFinance Mainstay Medical Holdings Plc is a medical device company, which focuses on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling mechanical Chronic Low Back Pain. The company was founded in 2020 and is headquartered in Dublin, Ireland. | Financial Conglomerates | Director/Board Member | |
Egle Therapeutics SAS
![]() Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Healthtech For Care | Corporate Officer/Principal | ||
Life Sciences Acceleration Alliance eV | Director/Board Member |
Statistieken
Internationaal
Frankrijk | 32 |
Verenigde Staten | 6 |
Canada | 4 |
Zwitserland | 3 |
Duitsland | 3 |
Sectoraal
Health Technology | 25 |
Finance | 8 |
Consumer Services | 6 |
Commercial Services | 4 |
Technology Services | 3 |
Operationeel
Director/Board Member | 141 |
Corporate Officer/Principal | 40 |
Independent Dir/Board Member | 19 |
Chief Executive Officer | 18 |
Chairman | 18 |
Sterkste connecties
Insiders | |
---|---|
Pierre Legault | 45 |
François Miceli | 43 |
Mounia Chaoui-Roulleau | 27 |
Thierry Laugel | 18 |
Gilles Alberici | 18 |
Lena Elisabeth Svanberg | 16 |
James Hindman | 14 |
Cédric Moreau | 14 |
Naveed Iqbal Siddiqi | 12 |
André de Villers | 11 |
Ezio Ghigo | 11 |
Aart Jan van der Lely | 10 |
Felice Verduyn-van Weegen | 9 |
Soraya Allas | 4 |
Christine Guillen | 3 |
- Beurs
- Insiders
- Thierry Abribat
- Bedrijfsconnecties